In part eight of this 8-part series, the Pediatric ID Board Certifying Examination Content related to TB is presented by expert speakers via case-based, interactive live webinars. The series goes beyond basic TB concepts while following the pediatric ID guidelines. This session focuses on pharmacotherapeutic of TB drugs.
Objectives
-
Describe general principles of antimicrobial use including:
-
Pharmacokinetic principles of absorption, distribution, metabolism, half-life, clearance and elimination.
-
Monitoring for toxicity/efficacy.
-
Describe the spectrum of activity, mechanism of action, routes of administration, adverse effects, common drug interactions of antimycobacterial agents.
-
Identify the uses of therapeutic drug monitoring.
For a link to the slides handout go to: https://sntc.medicine.ufl.edu//Content/Webinars/SupportingDocs//1Handout%20-%20Peloquin.pdf
For a link to the transcript go to: https://sntc.medicine.ufl.edu//Content/Webinars/SupportingDocs//Script%20-%20Peloquin.pdf
Additional courses in TB pediatric series: TB-253a, TB-253b, TB-253c, TB-253d, TB-253e, TB-253f, TB-253g
Keywords: TB, tuberculosis, TB disease, MTB, Mycobacterium tuberculosis, Latent TB infection, LTBI, Latent Tuberculosis Infection, MTB complex, children, infants, pediatrician